Hepatic Encephalopathy clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for

  • Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

    open to eligible people ages 18 years and up

    This is a global study to compare the effects of AXA1665, an orally active mixture of amino acids, compared to placebo, on cognitive and physical function, as well as the safety and tolerability of AXA1665.

    San Francisco, California and other locations

  • TReatment for ImmUne Mediated PathopHysiology

    Sorry, not currently recruiting here

    TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.

    San Francisco, California and other locations

Last updated: